StartupsTechNodeabout 2 hours ago
NeuroXess Raises RMB 700 Million in Series B
1 min read
Chinese brain-computer interface startup NeuroXess raised RMB 700 million in Series B funding co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital. The company will use proceeds for clinical trials, regulatory submissions, manufacturing capacity and next-generation product development. NeuroXess has completed 65 clinical cases and launched a registration trial involving nearly 20 hospitals in July.
Level
Hype check
Tap to vote and see what everyone thinks.
